Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoplasm of Female Breast”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableWithdrawnNCT01445275
What this trial is testing

Cost of Cancer Risk Management in Women at Elevated Genetic Risk for Ovarian Cancer Who Participated on GOG-0199

Who this might be right for
Fallopian Tube CarcinomaHereditary Breast and Ovarian Cancer SyndromeOvarian Carcinoma+1 more
Gynecologic Oncology Group
Testing effectiveness (Phase 2)Ended earlyNCT00082667
What this trial is testing

Gefitinib Followed By Surgery in Treating Women With Ductal Carcinoma In Situ of the Breast

Who this might be right for
Breast Cancer
Vanderbilt-Ingram Cancer Center 1
Not applicableStudy completedNCT01723592
What this trial is testing

Orall Administered Probiotics to Improve the Quality of the Vaginal Flora of Women With Breast Cancer and Chemotherapy.

Who this might be right for
Breast Cancer
Medical University of Vienna 27
Not applicableUnknownNCT02992730
What this trial is testing

Predictors of Adjuvant Endocrine Therapy in Women With Breast Cancer

Who this might be right for
Breast Cancer Female
Georgetown University 630
Not applicableStudy completedNCT00418444
What this trial is testing

Body Image and Psychosocial Functioning in Women With Breast Cancer: Can We Fix What We've Broken?

Who this might be right for
Breast Neoplasms
University Health Network, Toronto 180
Not applicableStudy completedNCT03676257
What this trial is testing

Survival Endpoints in Women Treated for Metastatic Breast Cancer: Contribution of Real-life Databases

Who this might be right for
Metastatic Breast Cancer
Institut Bergonié 20,033
Post-approval studies (Phase 4)Ended earlyNCT05183828
What this trial is testing

Effect of HSD3B1 (1245C) Gene Mutation on Treatment of Stage I-III Breast Cancer

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8+2 more
University of Washington 62
Testing effectiveness (Phase 2)UnknownNCT06176339
What this trial is testing

Assessing the Clinical Utility of Adding Pentoxifylline to Neoadjuvant Chemotherapy Protocols in Breast Cancer Patients"

Who this might be right for
Breast Cancer Female
Mansoura University 70
Not applicableEnded earlyNCT01303419
What this trial is testing

Contrast-Enhanced Digital Mammography (CEDM) for Identifying a Change in Management of Women With Newly Diagnosed Breast Cancer

Who this might be right for
Breast Cancer
GE Healthcare 224
Large-scale testing (Phase 3)UnknownNCT00402519
What this trial is testing

APBI Versus EBRT Therapy After Breast Conserving Surgery for Low-risk Breast Cancer

Who this might be right for
Breast Cancer
University of Erlangen-Nürnberg Medical School 1,300
Testing effectiveness (Phase 2)Looking for participantsNCT04503265
What this trial is testing

A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies

Who this might be right for
Advanced Malignant NeoplasmBreast CancerOvarian Cancer+3 more
AtlasMedx, Incorporated 122
Early research (Phase 1)UnknownNCT05273944
What this trial is testing

Bioequivalence Study of Doxorubicin Hydrochloride Liposome Injection (Lipodox®) in Chinese Patients

Who this might be right for
Breast CancerOvarian Cancer
Shenzhen Kangzhe Pharmaceutical Co., Ltd. 80
Large-scale testing (Phase 3)UnknownNCT00966888
What this trial is testing

Radiation Therapy or Standard Therapy in Treating Women With Stage II Breast Cancer Who Have Undergone Mastectomy

Who this might be right for
Breast Cancer
Medical Research Council 3,500
Post-approval studies (Phase 4)Study completedNCT05631795
What this trial is testing

Study to Assess the Safety of Alpelisib Plus Fulvestrant, in Men and Post-menopausal Women With HR-positive, HER2-negative, Advanced Breast Cancer (aBC) With PIK3CA Mutation, Whose Disease Progressed on or After Endocrine Treatment

Who this might be right for
Advanced Breast Cancer
Novartis Pharmaceuticals 40
Early research (Phase 1)Study completedNCT00001302
What this trial is testing

A Phase I Study of Infusional Chemotherapy With the P-Glycoprotein Antagonist PSC 833

Who this might be right for
Breast CancerKidney NeoplasmLymphoma+2 more
National Cancer Institute (NCI) 80
Testing effectiveness (Phase 2)Study completedNCT00064311
What this trial is testing

Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
National Institutes of Health Clinical Center (CC)
Not applicableUnknownNCT06468566
What this trial is testing

Identification of Benign and Malignant Breast Nodules Using Ultrasound-modulated Optical Tomography: A Multicenter Study

Who this might be right for
Breast Cancer Female
Xin-Wu Cui 2,000
Not applicableStudy completedNCT02501031
What this trial is testing

Flaxseed Intervention Study to Assess Sex Hormone Levels Among Post-Menopausal Women

Who this might be right for
Healthy
Cancer Care Ontario 99
Not applicableUnknownNCT06080607
What this trial is testing

PRO Survivorship Concerns ITA

Who this might be right for
Breast Neoplasm FemaleQuality of LifePsychological Distress
Regina Elena Cancer Institute 280
Testing effectiveness (Phase 2)WithdrawnNCT01137994
What this trial is testing

A Phase II, Randomized, Open-label Study of Lapatinib Plus Chemotherapy Versus Trastuzumab Plus Chemotherapy in HER2-positive and p95HER2-positive Metastatic Breast Cancer

Who this might be right for
Neoplasms, Breast
GlaxoSmithKline
Next Page